The prime goal of this core is to provide expert histopathology services, facilities, and resources for investigations involving cell and tissue microscopic analyses. Our Histopathology Core was established in 2004 with funding from the COBRE in Stem Cell Biology and Regenerative Medicine (8P20GM103465), with Dr. Volkhard Lindner as the Core Director. The success of this core has engaged all Center investigators, attracted many investigators from our Institute?s COBRE in Vascular Biology and Maine Medical Center, and a number of regional clients. Current services provided include the fixation and processing of specimens for frozen, paraffin and plastic embedded sectioning. A comprehensive spectrum of histological stains and specialty stains are offered. Detection of specific proteins by immunohistochemistry (IHC) is a key service, and our staff expertly develops and optimizes antigen retrieval, analysis, and versatile detection methods. This core facility has also developed and characterized highly specific rabbit monoclonal antibodies for the detection of several antigens where quality antibodies do not exist. In transitioning to Phase III, we outline several innovative features. First, we recently have developed the capacity to prepare custom tissue microarrays, and this is being applied to genetically engineered mouse models, human specimens, and mice generated from the Knockout Mutant Mouse Project (KOMP) at The Jackson Laboratory. This core will collaborate with the Mouse Transgenic Core of our sister COBRE in Vascular Biology to generate unique tissue arrays from this mutant mouse resource. In addition, Histopathology will collaborate with our Molecular Phenotyping Core (Oxburgh) to facilitate quantitative analysis of immunostained antigens. The ability to quantify both histological and immunostained specimens will significantly sharpen cellular and pathological phenotypic analysis of disease models and human pathological specimens. Thus, for Phase-Ill, our Histopathology Core is well-positioned to provide, and expand, comprehensive expert analyses of a broad spectrum of cell and tissue specimens.
RELEVANCE (See instructions): The vast majority of federally funded research at MMCRI has needs for histology services. The Histopathology Core will continue to deliver these services in an expert and timely manner. In addition, the Core will expand in innovative areas such as custom tissue microarray generation in collaboration with the Maine Medical Center Tissue Bank and the Knockout Mutant Mouse Project (KOMP) at The Jackson Laboratory.
|Ufkin, Melanie L; Peterson, Sarah; Yang, Xuehui et al. (2014) miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res 38:402-10|
|Guay, Justin A; Wojchowski, Don M; Fang, Jing et al. (2014) Death associated protein kinase 2 is expressed in cortical interstitial cells of the mouse kidney. BMC Res Notes 7:345|
|Favreau, Amanda J; Vary, Calvin P H; Brooks, Peter C et al. (2014) Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia. Cancer Med 3:265-72|
|Han, Xiang Hua; Jin, Yong-Ri; Tan, Leonard et al. (2014) Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/*-catenin pathway in skeletal myogenesis. Mol Cell Biol 34:752-64|
|Peterson, Sarah M; Thompson, Jeffrey A; Ufkin, Melanie L et al. (2014) Common features of microRNA target prediction tools. Front Genet 5:23|
|Verma, Rakesh; Su, Su; McCrann, Donald J et al. (2014) RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development. J Exp Med 211:1715-22|
|Fetting, Jennifer L; Guay, Justin A; Karolak, Michele J et al. (2014) FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney. Development 141:17-27|
|Guntur, Anyonya R; Le, Phuong T; Farber, Charles R et al. (2014) Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass. Endocrinology 155:1589-95|
|Li, Lei; Byrne, Susan M; Rainville, Nicole et al. (2014) Brief report: serpin Spi2A as a novel modulator of hematopoietic progenitor cell formation. Stem Cells 32:2550-6|